SIRT1 mediates the inhibitory effect of Dapagliflozin on EndMT by inhibiting the acetylation of endothelium Notch1

BACKGROUND: Endothelial–mesenchymal transition (EndMT) plays a crucial role in promoting myocardial fibrosis and exacerbating cardiac dysfunction. Dapagliflozin (DAPA) is a sodium–glucose-linked transporter 2 (SGLT-2) inhibitor that has been shown to improve cardiac function in non-diabetic patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Weijie, Li, Yilan, Zhang, Yanxiu, Ye, Tao, Wang, Kui, Li, Shuijie, Zhang, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685714/
https://www.ncbi.nlm.nih.gov/pubmed/38017499
http://dx.doi.org/10.1186/s12933-023-02040-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685714/
https://www.ncbi.nlm.nih.gov/pubmed/38017499
http://dx.doi.org/10.1186/s12933-023-02040-x

Ejemplares similares